News + Filings Transactions
|
Bitterman Kevin
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/15/2023 | Disc Medicine, Inc. | | Sale | Common Stock | 72.9k | $52.40 | $3.8M | See footnote | 08/15/2023 |
| 06/09/2023 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 7.1k | $45.69 | $326k | | 06/09/2023 |
| 12/29/2022 | Disc Medicine, Inc. | | Grant | Stock Option (Right to Buy) | 7k | $13.50 | $94.5k | | 12/29/2022 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 16.5k | $26.28 | $434.8k | See footnote | 06/01/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 945 | $26.28 | $24.8k | See footnote | 06/01/2021 |
| 06/01/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 13k | $26.32 | $342.2k | | 06/01/2021 |
| 10/09/2020 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 13k | $28.93 | $376.1k | See footnote | 10/09/2020 |
| 06/01/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 13k | $25.20 | $327.6k | | 06/01/2020 |
| 11/08/2019 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 26k | $19.97 | $519.2k | | 11/08/2019 |
| 06/24/2019 | Akero Therapeutics, Inc. | AKRO | Conversion | Common Stock | 3.5M | $0.00 | $0 | See Footnote | 06/24/2019 |
| 06/24/2019 | Akero Therapeutics, Inc. | AKRO | Conversion | Common Stock | 235.1k | $0.00 | $0 | See Footnote | 06/24/2019 |
| 06/24/2019 | Akero Therapeutics, Inc. | AKRO | Purchase | Common Stock | 270k | $16.00 | $4.3M | See Footnote | 06/24/2019 |
| 06/24/2019 | Akero Therapeutics, Inc. | AKRO | Conversion | Series A Preferred Stock | 10.7M | $0.00 | $0 | See Footnote | 06/24/2019 |
| 06/24/2019 | Akero Therapeutics, Inc. | AKRO | Conversion | Series B Preferred Stock | 722.7k | $0.00 | $0 | See Footnote | 06/24/2019 |
| 06/15/2017 | Editas Medicine, Inc. | EDIT | Grant | Stock Option (right to buy) | 11.5k | $15.63 | $180.3k | | 06/15/2017 |
| 05/22/2017 | Editas Medicine, Inc. | EDIT | Sale | Common Stock | 1000k | $17.00 | $17M | See Footnote | 05/22/2017 |
| 12/06/2016 | Editas Medicine, Inc. | EDIT | Sale | Common Stock | 50k | $15.87 | $793.5k | See Footnote | 12/05/2016 |
| 12/05/2016 | Editas Medicine, Inc. | EDIT | Sale | Common Stock | 80k | $15.74 | $1.3M | See Footnote | 12/05/2016 |
| 06/07/2016 | GENOCEA BIOSCIENCES, INC. | GNCA | Grant | Stock Option (Right to Buy) | 15k | $4.64 | $69.6k | | 06/07/2016 |
|